Table 3. Changes in T-TAS^® Parameters, PT-INR and APTT at Trough and Peak in Blood in the Rivaroxaban and Apixaban Groups.

	Rivaroxaban (n = 6)		Apixaban (n = 10)
	Trough	Peak	Trough	Peak
AR-T10 (min)	9.2 ± 2.9	12.3 ± 2.3	11.9 ± 2.5	15.5 ± 3.2*
AR-T80 (min)	13.7 ± 3.2	18.3 ± 3.5*	18.3 ± 3.1†	22.0 ± 3.3*
PL-T10(min)	2.4 ± 0.7	2.4 ± 1.5	2.9 ± 1.3	3.5 ± 1.0
PL-T60 (min)	6.7 ± 1.3	6.2 ± 0.8	8.3 ± 0.8	8.0 ± 0.3
PT-INR	1.2 ± 0.2	1.3 ± 0.2	1.1 ± 0.1	1.2 ± 0.1
APTT (s)	34.4 ± 5.3	40.7 ± 14.3	31.4 ± 2.3	31.9 ± 2.8

Continuous variables are expressed as mean ± SD. *P < 0.05 vs. trough, †P < 0.05 vs. rivaroxaban group.